Therapy of advanced acute myeloblastic leukemia with cytarabine and interleukin 2

This publication has 10 references indexed in Scilit:

• Acute myeloid leukaemia relapsing following interleukin-2 treatment expresses the alpha chain of the interleukin-2 receptor
  British Journal of Haematology, 1991
• Graft-versus-leukemia reactions after bone marrow transplantation
  Blood, 1990
• Induction and Persistence of Complete Remission in a Resistant Acute Myeloid Leukemia Patient after Treatment with Recombinant Interleukin-2
  Leukemia & Lymphoma, 1990
• Assay of lymphokine-activated killer activity generated from bone marrow cells of children with acute lymphoblastic leukemia
  Blood, 1990
• Effects of recombinant interleukin-2 administration on cytotoxic function following high-dose chemo-radiotherapy for hematological malignancy
  Blood, 1989
• Interleukin-2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients: II. Feasibility of LAK generation in children with active disease and in remission
  Blood, 1989
• Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy.
  Journal of Clinical Oncology, 1989
• A sensitive test for the detection of NK activity
  Journal of Immunological Methods, 1988
• The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
  The Journal of Immunology, 1986
• Comparison of chemotherapy with immunotherapy for maintenance of acute lymphoblastic leukemia in children and adults
  Blood, 1983